Price$2.34-0.01 (-0.43%)
02:00 PM06:15 PM
News · 26 weeks48-67%
2026-02-012026-07-26
Mix2290d
- Market10(45%)
- Insider9(41%)
- SEC Filings3(14%)
Latest news
25 items- NEWSModular Medical Announces Formation of Pivot Innovation Council and Appointment of Robert Gabbay, MD, PhD, FACP as Chairman- Council to Provide Strategic Clinical Guidance on Commercialization, Patient Identification, Workflow Integration, and Evidence Generation SAN DIEGO, CA / ACCESS Newswire / July 23, 2026 / Modular Medical, Inc, ("Modular Medical" or "the Company") (NASDAQ:MODD), a commercial-stage medical device company preparing for the commercial launch of its next-generation Pivot™ tubeless patch pump, today announced the formation of its Pivot Innovation Council, a cross-functional group of leading clinicians and healthcare experts established to help guide the company's clinical and commercial strategy. Diabetes care expert Robert Gabbay, MD, PhD, FACP was appointed as chair of the Pivot Innovation Co
- NEWSModular Medical and IMO Health Launch Strategic Pilot to Enable Real Time Insulin Pump Patient Identification Into Electronic Health RecordsPilot Combines Clinician Guided Phenotypes with IMO Health's Unique Terminology Identifiers to Help Clinicians Easily Identify Patients Most Likely to Benefit from Pivot Insulin Pump TherapyAdvancing Towards Fourth Quarter Commercial Launch of Pivot Pump SAN DIEGO, CA AND ROSEMONT, IL / ACCESS Newswire / July 16, 2026 / Modular Medical, Inc., ("Modular Medical" or "the Company") (NASDAQ:MODD), a commercial-stage medical device company preparing for the commercial launch of its next-generation Pivot™ tubeless patch pump, today announced an important pilot collaboration with IMO Health, whose expert-curated clinical terminology and accountable healthcare AI solutions are used across nearly all
- NEWSModular Medical Receives Research Demonstrating Positive Payor Reception of Pivot Tubeless Patch PumpCompleted Independent Study Strongly Supports Favorable Payor Receptivity to Pivot's Differentiated Design and Simplified User Experience, and provides further validation of significant progress towards goal of achieving broad market access for Pivot SAN DIEGO, CA / ACCESS Newswire / July 15, 2026 / Modular Medical, Inc. ("Modular Medical" or "the Company") (NASDAQ:MODD), a commercial-stage medical device company that is commercializing the next generation of insulin delivery technology, today released findings from an independent market research study demonstrating positive receptivity to its FDA-cleared Pivot™ tubeless patch pump due to its differentiated design, streamlined user experienc
- NEWSModular Medical Announces Completion of Research Initiative Indicating Strong Interest in Simpler Insulin Delivery97% of Surveyed Injection Users Would Consider Pump Therapy - if Easier to Learn and Improved OutcomesConducting Additional Research Initiative in Conjunction with Commercialization of the Pivot Tubeless Insulin Patch PumpCompany to Showcase Pivot at Association of Diabetes Care & Education Specialists (ADCES) Annual Conference, August 7-10, 2026 SAN DIEGO, CA / ACCESS Newswire / July 14, 2026 / Modular Medical, Inc. ("Modular Medical" or "the Company") (NASDAQ:MODD), a commercial-stage medical device company that is commercializing the next generation of insulin delivery technology, today announced positive findings from a new comprehensive diabetes patient research initiative further suppo
- INSIDERSEC Form 4 filed by Director Vos Ellen O'Connor4 - Modular Medical, Inc. (0001074871) (Issuer)
- INSIDERSEC Form 4 filed by Director Sheibley Philip Brent4 - Modular Medical, Inc. (0001074871) (Issuer)
- INSIDERSEC Form 4 filed by Director Goldberg Jeff D4 - Modular Medical, Inc. (0001074871) (Issuer)
- INSIDERDirector Felsher Steven G was granted 25 shares, increasing direct ownership by 0.30% to 8,498 units (SEC Form 4)4 - Modular Medical, Inc. (0001074871) (Issuer)
- INSIDERDirector Volkart Carmen B was granted 110 shares, increasing direct ownership by 14% to 916 units (SEC Form 4)4 - Modular Medical, Inc. (0001074871) (Issuer)
- INSIDERDirector Desisto Duane M was granted 83 shares, increasing direct ownership by 0.97% to 8,627 units (SEC Form 4)4 - Modular Medical, Inc. (0001074871) (Issuer)
- INSIDERSEC Form 4 filed by Director Frank Morgan C.4 - Modular Medical, Inc. (0001074871) (Issuer)
- NEWSModular Medical Announces FDA Submission of Pivot Tubeless Insulin Patch Pump EnhancementsSubmission Covers Software Enhancements for Patient Flexibility and Customization of Pivot SAN DIEGO, CA / ACCESS Newswire / July 1, 2026 / Modular Medical, Inc. ("Modular Medical" or "the Company") (NASDAQ:MODD), a leader in innovative, patient-centric insulin delivery technology, today announced submission to the U.S. Food & Drug Administration (FDA) of a series of software enhancements to its PivotTM insulin delivery system, providing users with more customization options and user-interface (UI) improvements, as well as other software upgrades."This submission is the first of a series of further improvements and upgrades planned for the Pivot platform, now that our core form factor has be
- NEWSModular Medical Delivers Insulin to First Patients on Pivot Tubeless Insulin Patch PumpFirst Patients Began Device Training and Insulin Delivery Today, Marking Transition to a Commercial CompanyPivot is the First Insulin Pump Designed to Address the Large, Underserved Population of Insulin-Dependent Adults Still Relying on Multiple Daily Injections, a Multibillion-Dollar Market SAN DIEGO, CO / ACCESS Newswire / June 30, 2026 / Modular Medical, Inc. ("Modular Medical" or "the Company") (NASDAQ:MODD), a leader in innovative, patient-centric insulin delivery technology, today announced that the first patients have completed onboarding and training and are now actively using the Pivot™ tubeless insulin patch pump in real-world settings.This milestone marks the transition of the Pi
- SECSEC Form 10-K filed by Modular Medical Inc.10-K - Modular Medical, Inc. (0001074871) (Filer)
- NEWSModular Medical Announces Shipment of Pivot Tubeless Patch PumpsPivot starter kits are now shipping to multiple endocrinology practices SAN DIEGO, CA / ACCESS Newswire / June 26, 2026 / Modular Medical, Inc. (NASDAQ:MODD) ("Modular Medical" or the "Company"), a leader in innovative, patient-centric insulin delivery technology, today announced that the Pivot™ tubeless insulin patch pump is now shipping to physician offices for training. Upon completion of training, these pumps will be presented to potential patients in the next few days and weeks. The Company intends to expand the roster of practices that offer Pivot over the coming months.This is another significant milestone in the deployment of Pivot. Modular Medical looks forward to updating the marke
- NEWSModular Medical Announces Commercial Availability of Pivot Tubeless Insulin Patch Pump Ahead of Commercial ExpansionThe Pivot tubeless insulin patch pump is now commercially available in the U.S. following FDA 510(k) clearance in AprilPivot represents a differentiated solution for insulin-dependent adults still on multiple daily injections, representing a multi-billion-dollar marketCommercial expansion activities are expected to begin in Q4 2026 SAN DIEGO, CA / ACCESS Newswire / June 24, 2026 / Modular Medical, Inc. (NASDAQ:MODD), a leader in innovative, patient-centric insulin delivery technology, today announced that the Pivot™ tubeless insulin patch pump is now commercially available. This marks the start of real-world patient use, and the Company's transition to a commercial-stage medical device compa
- NEWSModular Medical Launches New Website for Pivot Tubeless Insulin Patch PumpInitial patients expected in June 2026 SAN DIEGO, CA / ACCESS Newswire / June 4, 2026 / Modular Medical, Inc. ("Modular Medical" or the "Company") (NASDAQ:MODD), a leader in innovative, patient-centric insulin delivery, today announced the launch of PivotPump.com, a patient-focused website designed to support individuals seeking a simpler path to insulin pump therapy.This launch follows the Company's receipt of U.S. Food and Drug Administration ("FDA") clearance in April 2026 for its Pivot™ insulin delivery system. The FDA clearance represents a significant milestone in Modular Medical's strategy to expand access to insulin pump technology, particularly among individuals historically underse
- SECModular Medical Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits8-K - Modular Medical, Inc. (0001074871) (Filer)
- INSIDERSEC Form 4 filed by Officer Diperna Paul4 - Modular Medical, Inc. (0001074871) (Issuer)
- INSIDERSEC Form 4 filed by Chief Operating Officer Schmid Kevin4 - Modular Medical, Inc. (0001074871) (Issuer)
- SECSEC Form EFFECT filed by Modular Medical Inc.EFFECT - Modular Medical, Inc. (0001074871) (Filer)
- NEWSRegistration Is Now Open For Tribe Public's CEO Presentation and Q&A Webinar Event Titled "From FDA Wins to Scaling Manufacturing - What Investors Should Watch." Featuring Modular Medical CEO - Friday, May 1, 2026Meet with Modular Medical CEO Jeb BesserThere are 4.8 million individuals with diabetes in the US that require daily insulin. Only 20% currently use an insulin pump.Discover Modular Medical's Pivot, the first FDA-cleared, two-part tubeless patch pump featuring a removable 3 mL reservoir, disposable battery, smartphone connectivity for bolus and monitoring, and true electronic accuracy without tubes or constant wear and its associated commercial & manufacturing timeline.Register at MODD-May-Watch.TribePublic.com SAN DIEGO, CA / ACCESS Newswire / April 29, 2026 / Modular Medical, Inc. (NASDAQ:MODD) ("Modular Medical" or the "Company"), a leader in innovative, patient-centric insulin delivery,
- SECSEC Form S-3 filed by Modular Medical Inc.S-3 - Modular Medical, Inc. (0001074871) (Filer)
- SECModular Medical Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits8-K - Modular Medical, Inc. (0001074871) (Filer)
- SECSEC Form 424B5 filed by Modular Medical Inc.424B5 - Modular Medical, Inc. (0001074871) (Filer)
MODD FAQ
5 questionsWhat does Modular Medical Inc. do?
Modular Medical, Inc., a development stage medical device company, focuses on the design, development, and commercialization of insulin pumps using technology to enhance pump adoption in the diabetes marketplace. The company is headquartered in San Diego, California.Where does MODD stock trade?
Modular Medical Inc. (MODD) is listed on NASDAQ.What sector and industry is MODD in?
Modular Medical Inc. operates in the Health Care sector, Medical/Dental Instruments industry.What companies are similar to MODD?
Notable peers in the same industry include SYK (Stryker Corporation), MMM (3M Company), BSX (Boston Scientific Corporation), MDLN (Medline Inc.), BDX (Becton Dickinson and Company). Compare MODD side-by-side with any of them on Quantisnow.How can I track MODD on Quantisnow?
Quantisnow aggregates Modular Medical Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow MODD to receive live email and push alerts on every new disclosure.